We’re revolutionizing the logistics of personalized medicine

Our approach is different

Others have tried to bank immune cells for future cell therapies but we are taking a new tack:

  • There is no cost to patients

  • We collect, process and store cells so that they can be used for a future potential cell therapy option

  • We do not favor one cell therapy approach over another. Our aim is to provide as many choices for the patient as possible.

Our solution involves three stages

1. Informed Consent

  • You can learn more about our option at our For Patients page and look at our informed consent documents here.

    We encourage you to discuss our option with your doctor to see if it is right for you.

  • Our first efforts will support pediatric patients with r/r B-ALL and adult colorectal, gastric or neuroendocrine cancers.

    However, any cancer patient who provides consent can take advantage of our service to alert them of new personalized medicines that may be relevant for them.

    Please contact us to learn more.

  • Achieve Clinics only banks cells from patients who may qualify for your technology. To get started, all we require is a signed letter of intent that you are willing to consider patients we bank.

    There is no cost to you for us to start banking patients, and once we do, we can make a portion of their collected cells available for your process development work or other R&D needs.

    Please contact us to learn more about how we collect and process cells and how we can help support your research.

2. Cell collection and storage

  • If our team of medical professionals agree that you are a good fit for one of our cell therapies, we will invite you to undergo a cell collection procedure called apheresis.

    Check out this youtube video to learn more about apheresis. This procedure is so safe that healthy people like the person in this video undergo the procedure voluntarily to donate immune cells for someone else. At Achieve Clinics, patients are the recipients of their own cells.

    Once we have your cells, we store them safely off-site until you need them for a cell therapy. If you don’t end up needing the cells we collected, then we ask for your consent to provide them to the research community.

  • At this point, we have determined that the patient is a good potential fit for a future cell therapy in our program but we still need you to formally refer them to us so that we know their apheresis is compatible with the standard of care you’re providing as well as their overall health.

  • Cell therapy developers will have access to a HIPAA-compliant de-identified register of the patients we are accessing and banking.

    This register can also be used to inquire about surplus cells from banked patients we can make available for research.

    This register to plan trial accrual.

3. Cell Therapy Access

  • This is the moment that Achieve Clinics has been working so hard for: When a patient like you gets a cell therapy faster than ever before.

    The cell therapy developer will work with us to determine which patients we bank should be enrolled into their trial. With your consent, we will connect them to you so can decide if you’d like to access their potentially lifesaving technology.

    Please note: we cannot guarantee that you will access a cell therapy.

  • Once a trial flags a patient for accrual, we will contact you and the patient to determine if proceeding is the right choice.

    We merely make this connection - the patient may still need to be referred to the site and must be consented to the trial sponsor’s protocol if the option is still experimental.

    In cases where Achieve Clinics has an FDA-approved option for a patient, they may still need to be referred to another hospital for infusion.

  • Once the patient and their oncologist confirm interest in your technology and provide the requisite consent, we will connect you to them to initiate the enrollment process.

    Once the paperwork is complete, we will send the cryopreserved cells to your manufacturing site at the time that works best for you and the patient.

    Payment to Achieve Clinics will be due in accordance with the terms of our customer agreement.

FAQs

  • In January 2025, the Baylor College of Medicine Insitutional Review Board approved our protocol to allow us to support B-ALL patients at Texas Children’s in Houston. Please contact the Principal Investigator, Dr. Rayne Rouce, for additional information.

    We will shortly be able to begin recruiting patients with colorectal, gastric or neuroendocrine cancer to support access to Chimeric Therapeutic’s CAR-T cell therapy.

    We expect to support many more patients in the near future. Please check our For Patients page for the most recent options available.

  • Achieve Clinics aspires to be a true decentralized clinical site network , meaning that it should not matter where patients live. This will require us to operate in many major cities throughout the United States.

    Today, we can accommodate collections in many cities nationwide thanks to our relationships with Blood Centers of America and Vitalant. Contact us to learn more!

  • Achieve Clinics reserves a large portion of a participating patient’s cells for their future use to make a cell therapy.

    But if we collect more cells, participating patients give us consent to provide them to the research community. These cells can support the work of scientists developing many different types of immuno-oncology drugs and the technologies used to manufacture them. These scientists, both in academia and industry, pay Achieve Clinics for access to these cells.

    The fees that Achieve Clinics charges researchers to access these cells enable this free-to-patient model.

  • No. We are laser focused on helping the most vulnerable populations. Our priority is to partner with as many clinical stage cell therapy companies as possible, as fast as possible, so we can offer the most options to the widest swath of patients.

  • Yes! You do not need to give us your cells for us to notify you about treatment options relevant to your diagnosis.

    But in this case, you still need to give us permission to obtain and review your medical records, and share them with third parties as needed, to help facilitate this free-to-patient concierge oncology service.